|
|
|
 |
Ò©µê¹ú±ð£º |
|
²úµØ¹ú¼Ò£º | ÈÕ±¾ |
´¦ ·½ Ò©£º | ÊÇ |
ËùÊôÀà±ð£º | 500ºÁ¿Ë/Æ¿ 5Æ¿/ºÐ |
°ü×°¹æ¸ñ£º |
500ºÁ¿Ë/Æ¿ 5Æ¿/ºÐ |
¼Æ¼Ûµ¥Î»£º |
ºÐ |
Éú²ú³§¼ÒÖÐÎIJο¼ÒëÃû: |
ŵ»ªÖÆÒ© |
Éú²ú³§¼ÒÓ¢ÎÄÃû: |
Novartis Pharma Corporation |
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·1: |
https://www.info.pmda.go.jp/go/pack/3929402D1036_1_08/ |
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·2: |
|
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·3: |
|
|
Ô²úµØÓ¢ÎÄÉÌÆ·Ãû: |
Desferal£¨¥Ç¥¹¥Õ¥§¥é©`¥ë×¢ÉäÓã©500mg/Vial 5Vial/box |
Ô²úµØÓ¢ÎÄÒ©Æ·Ãû: |
Deferoxamine Mesilate |
ÖÐÎIJο¼ÉÌÆ·ÒëÃû: |
Desferal£¨¥Ç¥¹¥Õ¥§¥é©`¥ë×¢ÉäÓã©500ºÁ¿Ë/Æ¿ 5Æ¿/ºÐ |
ÖÐÎIJο¼Ò©Æ·ÒëÃû: |
¼×»ÇËáÈ¥Ìú°· |
ÔøÓÃÃû: |
|
|
|